Premier Alternatives

Avistone Pharmaceuticals Biotechnology

Beijing, China · Founded 2018 · In IPO Registration

Developer of innovative drugs for tumor treatment. Avistone Pharmaceuticals Biotechnology is based in Beijing, China and was founded in 2018. Its last reported valuation was $628 million in Mar 2025. It has raised $372 million.

Last reported valuation
$628.3M
Oct 2026
Priced at
—
Total raised
$372.0M
Last round
—
How much has Avistone Pharmaceuticals Biotechnology raised?
$372.0Macross 0 recorded rounds
Free account
More of Avistone Pharmaceuticals Biotechnology with a free account
  • ·The complete investor list: 11 names
  • ·Watch Avistone Pharmaceuticals Biotechnology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Avistone Pharmaceuticals Biotechnology investors

11 investors are on record for Avistone Pharmaceuticals Biotechnology, including IDG Capital, Bain Capital, Cathay Capital and CMG SDIC Fund. By type, the record holds 4 venture capital firms, 2 private equity firms and 1 growth equity firm.

For fundraisers
Raising for a company like Avistone Pharmaceuticals Biotechnology?

11 investors have backed Avistone Pharmaceuticals Biotechnology.

See all 11 investors →

Frequently asked about Avistone Pharmaceuticals Biotechnology

How much has Avistone Pharmaceuticals Biotechnology raised?
Avistone Pharmaceuticals Biotechnology has raised $372.0M in total across 0 recorded funding rounds.